Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Landa Magdalena

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Palliative Medicine|September 5, 2025
Mapping palliative care for people living with advanced cancer in phase 1 clinical trials: A scoping reviewDiego Candelmi, Alazne Belar, Carla Zapata Del Mar, et al.
Cancers|September 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena, et al.
British Journal of Cancer|July 6, 2021
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Journal of Hepatology|February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA RegistryLaura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Nature|February 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature|December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Palliative Medicine|September 5, 2025
Mapping palliative care for people living with advanced cancer in phase 1 clinical trials: A scoping reviewDiego Candelmi, Alazne Belar, Carla Zapata Del Mar, et al.
Cancers|September 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena, et al.
British Journal of Cancer|July 6, 2021
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Journal of Hepatology|February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA RegistryLaura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Nature|February 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature|December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Pageof 1